Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Assets (2016 - 2025)

Guided Therapeutics' Return on Assets history spans 14 years, with the latest figure at 2.85% for Q3 2025.

  • For Q3 2025, Return on Assets fell 113.0% year-over-year to 2.85%; the TTM value through Sep 2025 reached 2.85%, down 113.0%, while the annual FY2024 figure was 1.59%, 20.0% down from the prior year.
  • Return on Assets for Q3 2025 was 2.85% at Guided Therapeutics, down from 2.67% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.99% in Q2 2021 and bottomed at 2.85% in Q3 2025.
  • The 5-year median for Return on Assets is 1.72% (2024), against an average of 1.5%.
  • The largest YoY upside for Return on Assets was 568bps in 2021 against a maximum downside of -322bps in 2021.
  • A 5-year view of Return on Assets shows it stood at 1.09% in 2021, then decreased by -10bps to 1.2% in 2022, then plummeted by -64bps to 1.97% in 2023, then increased by 6bps to 1.84% in 2024, then tumbled by -55bps to 2.85% in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Return on Assets are 2.85% (Q3 2025), 2.67% (Q2 2025), and 2.08% (Q1 2025).